Skip to main content
Erschienen in: Obesity Surgery 3/2018

30.09.2017 | Original Contributions

Bariatric Surgery can Reduce Albuminuria in Patients with Severe Obesity and Normal Kidney Function by Reducing Systemic Inflammation

verfasst von: Samel Park, Yong Jin Kim, Chi-young Choi, Nam-Jun Cho, Hyo-Wook Gil, Eun Young Lee

Erschienen in: Obesity Surgery | Ausgabe 3/2018

Einloggen, um Zugang zu erhalten

Abstract

Background

Obesity causes renal problems including albuminuria. Bariatric surgery (BS) improves albuminuria. We investigated whether albuminuria is reduced by weight loss per se or by improved systemic inflammation induced by weight loss after BS.

Methods

Patients older than 18 years who received BS in Soonchunhyang University Hospital from 01 January 2011 to 31 December 2011 were included. Other inclusion criteria included body mass index (BMI) ≥ 30 kg/m2, creatinine level ≤ 1.0 mg/dL, and no overt proteinuria (trace amount or undetectable by dipstick). The patients were followed at 1 and 6 months after BS.

Results

Forty-three patients were analyzed. Three patients were men, 10 patients had diabetes, and 12 patients had hypertension. All patients had normal renal function (creatinine ≤ 1.0 mg/dL), and estimated glomerular filtration rate was 115.7 ± 16.5 mL/min/1.73 m2. There were significant reductions in body weight, BMI, high-sensitivity C-reactive protein (hs-CRP), and urine albumin-to-creatinine ratio (ACR). There were positive correlations between delta hs-CRP and delta body weight (r = 0.349, p = 0.043) or delta body mass index (BMI, r = 0.362, p = 0.035); between hs-CRP and body weight (r = 0.374, p = 0.001), BMI (r = 0.431, p < 0.001). Multivariate analysis using a linear mixed model demonstrated that hs-CRP (β = 0.5364, p = 0.026) was an independent risk factor affecting ACR.

Conclusions

Our study suggests that BS can reduce albuminuria in patients with severe obesity and normal kidney function by reducing systemic inflammation.
Literatur
1.
Zurück zum Zitat Hawkins MA. Markers of increased cardiovascular risk: are we measuring the most appropriate parameters? Obes Res. 2004;12(Suppl 2):107s–14s.CrossRefPubMed Hawkins MA. Markers of increased cardiovascular risk: are we measuring the most appropriate parameters? Obes Res. 2004;12(Suppl 2):107s–14s.CrossRefPubMed
2.
Zurück zum Zitat Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults—the evidence report. Obes Res. 1998;6(Suppl 2):51s–209s. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults—the evidence report. Obes Res. 1998;6(Suppl 2):51s–209s.
3.
Zurück zum Zitat Wahba IM, Mak RH. Obesity and obesity-initiated metabolic syndrome: mechanistic links to chronic kidney disease. Clin J Am Soc Nephrol. 2007;2(3):550–62.CrossRefPubMed Wahba IM, Mak RH. Obesity and obesity-initiated metabolic syndrome: mechanistic links to chronic kidney disease. Clin J Am Soc Nephrol. 2007;2(3):550–62.CrossRefPubMed
4.
Zurück zum Zitat Wing RR. Long-term effects of a lifestyle intervention on weight and cardiovascular risk factors in individuals with type 2 diabetes mellitus: four-year results of the Look AHEAD trial. Arch Intern Med. 2010;170(17):1566–75.PubMed Wing RR. Long-term effects of a lifestyle intervention on weight and cardiovascular risk factors in individuals with type 2 diabetes mellitus: four-year results of the Look AHEAD trial. Arch Intern Med. 2010;170(17):1566–75.PubMed
5.
Zurück zum Zitat Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004;292(14):1724–37.CrossRefPubMed Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004;292(14):1724–37.CrossRefPubMed
6.
Zurück zum Zitat Navarro-Diaz M, Serra A, Lopez D, et al. Obesity, inflammation, and kidney disease. Kidney Int Suppl. 2008;111:S15–8.CrossRef Navarro-Diaz M, Serra A, Lopez D, et al. Obesity, inflammation, and kidney disease. Kidney Int Suppl. 2008;111:S15–8.CrossRef
7.
Zurück zum Zitat de Jong PE, Verhave JC, Pinto-Sietsma SJ, et al. Obesity and target organ damage: the kidney. Int J Obes Relat Metab Disord. 2002;26(Suppl 4):S21–4.CrossRefPubMed de Jong PE, Verhave JC, Pinto-Sietsma SJ, et al. Obesity and target organ damage: the kidney. Int J Obes Relat Metab Disord. 2002;26(Suppl 4):S21–4.CrossRefPubMed
8.
Zurück zum Zitat Serra A, Romero R, Lopez D, et al. Renal injury in the extremely obese patients with normal renal function. Kidney Int. 2008;73(8):947–55.CrossRefPubMed Serra A, Romero R, Lopez D, et al. Renal injury in the extremely obese patients with normal renal function. Kidney Int. 2008;73(8):947–55.CrossRefPubMed
9.
Zurück zum Zitat Bahrami H, Bluemke DA, Kronmal R, et al. Novel metabolic risk factors for incident heart failure and their relationship with obesity: the MESA (Multi-Ethnic Study of Atherosclerosis) study. J Am Coll Cardiol. 2008;51(18):1775–83.CrossRefPubMed Bahrami H, Bluemke DA, Kronmal R, et al. Novel metabolic risk factors for incident heart failure and their relationship with obesity: the MESA (Multi-Ethnic Study of Atherosclerosis) study. J Am Coll Cardiol. 2008;51(18):1775–83.CrossRefPubMed
10.
Zurück zum Zitat Ibsen H, Olsen MH, Wachtell K, et al. Reduction in albuminuria translates to reduction in cardiovascular events in hypertensive patients with left ventricular hypertrophy and diabetes. J Nephrol. 2008;21(4):566–9.PubMed Ibsen H, Olsen MH, Wachtell K, et al. Reduction in albuminuria translates to reduction in cardiovascular events in hypertensive patients with left ventricular hypertrophy and diabetes. J Nephrol. 2008;21(4):566–9.PubMed
11.
Zurück zum Zitat Ibsen H, Olsen MH, Wachtell K, et al. Reduction in albuminuria translates to reduction in cardiovascular events in hypertensive patients: losartan intervention for endpoint reduction in hypertension study. Hypertension. 2005;45(2):198–202.CrossRefPubMed Ibsen H, Olsen MH, Wachtell K, et al. Reduction in albuminuria translates to reduction in cardiovascular events in hypertensive patients: losartan intervention for endpoint reduction in hypertension study. Hypertension. 2005;45(2):198–202.CrossRefPubMed
12.
Zurück zum Zitat Navarro-Diaz M, Serra A, Romero R, et al. Effect of drastic weight loss after bariatric surgery on renal parameters in extremely obese patients: long-term follow-up. J Am Soc Nephrol. 2006;17(12 Suppl 3):S213–7.CrossRefPubMed Navarro-Diaz M, Serra A, Romero R, et al. Effect of drastic weight loss after bariatric surgery on renal parameters in extremely obese patients: long-term follow-up. J Am Soc Nephrol. 2006;17(12 Suppl 3):S213–7.CrossRefPubMed
13.
Zurück zum Zitat Bolignano D, Zoccali C. Effects of weight loss on renal function in obese CKD patients: a systematic review. Nephrol Dial Transplant. 2013;28(Suppl 4):iv82–98.CrossRefPubMed Bolignano D, Zoccali C. Effects of weight loss on renal function in obese CKD patients: a systematic review. Nephrol Dial Transplant. 2013;28(Suppl 4):iv82–98.CrossRefPubMed
14.
Zurück zum Zitat Huan Y, Tomaszewski JE, Cohen DL. Resolution of nephrotic syndrome after successful bariatric surgery in patient with biopsy-proven FSGS. Clini Nephrol. 2009;71(1):69–73.CrossRef Huan Y, Tomaszewski JE, Cohen DL. Resolution of nephrotic syndrome after successful bariatric surgery in patient with biopsy-proven FSGS. Clini Nephrol. 2009;71(1):69–73.CrossRef
15.
Zurück zum Zitat Alexander JW, Goodman HR, Hawver LR, et al. Improvement and stabilization of chronic kidney disease after gastric bypass. Surg Obes Relat Dis. 2009;5(2):237–41.CrossRefPubMed Alexander JW, Goodman HR, Hawver LR, et al. Improvement and stabilization of chronic kidney disease after gastric bypass. Surg Obes Relat Dis. 2009;5(2):237–41.CrossRefPubMed
16.
Zurück zum Zitat Pi-Sunyer X, Blackburn G, Brancati FL, et al. Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes: one-year results of the look AHEAD trial. Diabetes Care. 2007;30(6):1374–83.CrossRefPubMed Pi-Sunyer X, Blackburn G, Brancati FL, et al. Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes: one-year results of the look AHEAD trial. Diabetes Care. 2007;30(6):1374–83.CrossRefPubMed
17.
Zurück zum Zitat Wickman C, Kramer H. Obesity and kidney disease: potential mechanisms. Semin Nephrol. 2013;33(1):14–22.CrossRefPubMed Wickman C, Kramer H. Obesity and kidney disease: potential mechanisms. Semin Nephrol. 2013;33(1):14–22.CrossRefPubMed
18.
Zurück zum Zitat Neff KJ, Frankel AH, Tam FW, et al. The effect of bariatric surgery on renal function and disease: a focus on outcomes and inflammation. Nephrol Dial Transplant. 2013;28(Suppl 4):iv73–82.CrossRefPubMed Neff KJ, Frankel AH, Tam FW, et al. The effect of bariatric surgery on renal function and disease: a focus on outcomes and inflammation. Nephrol Dial Transplant. 2013;28(Suppl 4):iv73–82.CrossRefPubMed
19.
Zurück zum Zitat World Health Organization. The Asia-Pacific perspective: redefining obesity and its treatment. Sydney: Health Communications Australia; 2000. World Health Organization. The Asia-Pacific perspective: redefining obesity and its treatment. Sydney: Health Communications Australia; 2000.
21.
Zurück zum Zitat Kim EY, Kim YJ. Does bariatric surgery really prevent deterioration of renal function? Surg Obes Relat Dis. 2016;12(4):856–61.CrossRefPubMed Kim EY, Kim YJ. Does bariatric surgery really prevent deterioration of renal function? Surg Obes Relat Dis. 2016;12(4):856–61.CrossRefPubMed
22.
Zurück zum Zitat Agrawal V, Krause KR, Chengelis DL, et al. Relation between degree of weight loss after bariatric surgery and reduction in albuminuria and C-reactive protein. Surg Obes Relat Dis. 2009;5(1):20–6.CrossRefPubMed Agrawal V, Krause KR, Chengelis DL, et al. Relation between degree of weight loss after bariatric surgery and reduction in albuminuria and C-reactive protein. Surg Obes Relat Dis. 2009;5(1):20–6.CrossRefPubMed
23.
Zurück zum Zitat Fenske WK, Dubb S, Bueter M, et al. Effect of bariatric surgery-induced weight loss on renal and systemic inflammation and blood pressure: a 12-month prospective study. Surg Obes Relat Dis. 2013;9(4):559–68.CrossRefPubMed Fenske WK, Dubb S, Bueter M, et al. Effect of bariatric surgery-induced weight loss on renal and systemic inflammation and blood pressure: a 12-month prospective study. Surg Obes Relat Dis. 2013;9(4):559–68.CrossRefPubMed
24.
Zurück zum Zitat Scheven L, Joosten MM, de Jong PE, et al. The association of albuminuria with tubular reabsorption of uric acid: results from a general population cohort. J Am Heart Assoc. 2014;3(2):e000613.CrossRefPubMedPubMedCentral Scheven L, Joosten MM, de Jong PE, et al. The association of albuminuria with tubular reabsorption of uric acid: results from a general population cohort. J Am Heart Assoc. 2014;3(2):e000613.CrossRefPubMedPubMedCentral
25.
Zurück zum Zitat Ballantyne GH, Gumbs A, Modlin IM. Changes in insulin resistance following bariatric surgery and the adipoinsular axis: role of the adipocytokines, leptin, adiponectin and resistin. Obes Surg. 2005;15(5):692–9.CrossRefPubMed Ballantyne GH, Gumbs A, Modlin IM. Changes in insulin resistance following bariatric surgery and the adipoinsular axis: role of the adipocytokines, leptin, adiponectin and resistin. Obes Surg. 2005;15(5):692–9.CrossRefPubMed
26.
Zurück zum Zitat Niskanen LK, Haffner S, Karhunen LJ, et al. Serum leptin in obesity is related to gender and body fat topography but does not predict successful weight loss. Eur J Endocrinol. 1997;137(1):61–7.CrossRefPubMed Niskanen LK, Haffner S, Karhunen LJ, et al. Serum leptin in obesity is related to gender and body fat topography but does not predict successful weight loss. Eur J Endocrinol. 1997;137(1):61–7.CrossRefPubMed
27.
Zurück zum Zitat Czupryniak L, Pawlowski M, Kumor A, et al. Predicting maximum Roux-en-Y gastric bypass-induced weight reduction—preoperative plasma leptin or body weight? Obes Surg. 2007;17(2):162–7.CrossRefPubMed Czupryniak L, Pawlowski M, Kumor A, et al. Predicting maximum Roux-en-Y gastric bypass-induced weight reduction—preoperative plasma leptin or body weight? Obes Surg. 2007;17(2):162–7.CrossRefPubMed
28.
Zurück zum Zitat Mavri A, Stegnar M, Sabovic M. Do baseline serum leptin levels predict weight regain after dieting in obese women? Diabetes Obes Metab. 2001;3(4):293–6.CrossRefPubMed Mavri A, Stegnar M, Sabovic M. Do baseline serum leptin levels predict weight regain after dieting in obese women? Diabetes Obes Metab. 2001;3(4):293–6.CrossRefPubMed
Metadaten
Titel
Bariatric Surgery can Reduce Albuminuria in Patients with Severe Obesity and Normal Kidney Function by Reducing Systemic Inflammation
verfasst von
Samel Park
Yong Jin Kim
Chi-young Choi
Nam-Jun Cho
Hyo-Wook Gil
Eun Young Lee
Publikationsdatum
30.09.2017
Verlag
Springer US
Erschienen in
Obesity Surgery / Ausgabe 3/2018
Print ISSN: 0960-8923
Elektronische ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-017-2940-y

Weitere Artikel der Ausgabe 3/2018

Obesity Surgery 3/2018 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.